Exelixis (EXEL) Misses Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $51.91 --0%
EPS Growth %: +13.3%
Financial Fact:
Interest expense: -12.63M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +13.3%
Financial Fact:
Interest expense: -12.63M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q3 EPS of $0.10, $0.05 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $471.92 million versus the consensus estimate of $471.64 million.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion
- Morgan Stanley Resumes Global Payments (GPN) at Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
